September 2011

Marken launches new website and marketing campaign

Friday, September 30, 2011

Marken has launched a new global brand and advertising campaign to reflect the unique position that it holds in the pharmaceutical industry.  The campaign will be introduced globally with the launch of its new website and will include its new brand and tagline: “Global Life Science Supply Chain Solutions.”

[Read More]

Boston Scientific enrolls first patients in NECTAR-HF trial

Friday, September 30, 2011

Boston Scientific has enrolled the first patients in its NECTAR-HF (neural cardiac therapy for heart failure) clinical trial.  NECTAR-HF is a prospective, randomized, international clinical feasibility study designed to assess preliminary safety and efficacy of chronic vagal nerve stimulation in heart failure patients.  The study will evaluate 96 patients with vagal nerve stimulator implants at multiple centers in Europe.

[Read More]

ClinicalRM awarded two contracts to support Navy Medical Research Center

Friday, September 30, 2011

Clinical Research Management (ClinicalRM), a full-service contract research organization providing services for basic and applied research, clinical trials, and regulatory support, was awarded two contracts by the Navy Medical Research Center (NMRC) under its Omnibus III program. The awards are for the provision resources in support of NMRC, including: providing an infrastructure of personnel, materials, equipment, facilities, science, and technology that will sustain an acceptable level of medical research.

[Read More]

ProTip receives ESB translational research prize

Friday, September 30, 2011

ProTip, a company developing medical devices that bring innovative solutions to people suffering from dysfunctions of the larynx, was awarded the ESB Translational Research prize of the European Society for Biomaterials at the ESB annual congress in Dublin, Ireland. This prize, sponsored by the Swiss Society for Biomaterials, is designed to “support scientific efforts in translational research, i.e. scientific activities helping to transform a research idea into a product.”
 
This prize has been awarded for a research program launched by ProTip in 2010, aimed at developing a trachea implant made from a biodegradable microporous polymer and macroporous titanium.
 
“This reward proves that, with high enough focus on relevant and the right research activities, a young firm like ProTip can play an important role in a market as demanding and competitive as that of biomaterials,” said the chairman of ProTip, Maurice Bérenger.

[Read More]